StockCIK 2010788
EXOZYMES INC. (EXOZ): Insider Trades and Fund Holdings
In the past 12 months, EXOZYMES INC. insiders reported 2 open-market purchases worth $6K and 1 sale worth $19K; 0 of the sales were reported as made under a 10b5-1 trading plan.
2Insider buys, 12 months
$6KBought by insiders, 12 months
$19KSold by insiders, 12 months
0Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 26, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 26 | Damien Alan PerrimanChief Commercial Officer | ▼ SELL | $19K |
| Sep 2 | Michael HeltzenCEO | ▲ BUY | $4K |
| Sep 2 | Michael HeltzenCEO | ▲ BUY | $3K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Damien Alan Perriman | Chief Commercial Officer | 0 | $0 | 1 | $19K |
| Michael Heltzen | CEO | 2 | $6K | 0 | $0 |
ADVERTISEMENT
320 × 100 ad slot
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →